All Videos

A focused discussion on the benefit of bimekizumab, an IL-17A/IL-17F inhibitor, in the setting of moderate to severe plaque psoriasis.

What new treatments are coming to infectious disease? How can they be prevented and what misconceptions are affecting treatment? Learn about this and more in this video with Ted Rosen, MD.

Ted Rosen, MD, explains the top points of his presentation, "What's Hot and New in Infectious Disease?" from the 2022 Winter Clinical Dermatology Conference.

In this video interview, Peter A. Lio, MD, FAAD, expands on his Winter Clinical Dermatology 2022 presentation, "What's Hot and New in Pediatric Dermatology?" He talks the pipeline, black box warnings, and more on atopic dermatitis treatments.

In this video, Peter Lio, MD, FAAD, expands on his presentation at the 19th annual Winter Clinical Dermatology Conference by diving into molluscum contagiousum treatment and the potential of cantharidin 0.7% (VP-102; Verrica).

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses the story of how a hockey fan spotted a cancerous mole on the on the Canucks, a National Hockey League (NHL) Team, equipment manager.

A brief review of biologic agents being used or evaluated in the setting of plaque psoriasis.

Taking a broader look at moderate to severe plaque psoriasis, experts consider what the standard of care would be in different settings.

The panel reviews therapeutic classes and their respective benefits in patients being treated for plaque psoriasis.

In this week’s Pointers with Dr Portela, the 208SkinDoc had already called out the Green Mask Stick’s false advertising, but now the controversy continues.

Centering discussion on a case of plaque psoriasis, experts share their experience with patient counseling and selecting therapy.

Matthew Zirwas, MD, breaks down the safety of JAK inhibitors based on clinical trial data.

Key opinion leaders explain the box warnings and safety profiles of JAK inhibitors.

In this week’s Pointers with Dr Portela, the 208SkinDoc lists his favorite skincare products that he used this year.

Considerations for the psychological and social impact that plaque psoriasis may have on a patient.

Panelists look deeper into the possible challenges or barriers to making an accurate diagnosis of plaque psoriasis

In this week’s Pointers with Dr Portela, the 208SkinDoc goes into the science behind sleep and skin while also review 3 different sleep improvement devices.

Linda Stein Gold, MD, provides an overview of the four JAK inhibitors currently available for treating inflammatory diseases.

Shared insight on identifying clinical manifestations of plaque psoriasis and making a timely diagnosis.

A panel of experts review the nature of plaque psoriasis and the mechanism of action of several classes of targeted therapy.

Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/SGM Expert Resource Group, sits down with Dermatology Times® to discuss what changes were made to the iPLEDGE platform, examples of how the roll out has been unsuccessful, and how patients should be wary of trying to take old medications.

In this video interview, Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/SGM Expert Resource Group, explains what happened with the iPLEDGE website.

In this week’s Pointers with Dr Portela, the 208SkinDoc explains the differences between lasers that can be used for various treatment goals.

Looking toward the future management of vitiligo, expert dermatologists close out their discussion on JAK inhibition and other novel therapy.

Shared insight from dermatologists on novel topical JAK inhibitor therapy being investigated as an option for patients with vitiligo.

In this week’s Pointers with Dr Portela, the 208SkinDoc answers viewer questions about acne scarring including how to distinguish between acne scars and inflammatory pigment change.

A brief review of the treatment armamentarium for vitiligo, as well as the prevalent unmet needs in that setting.

Seemal Desai, MD, FAAD, and William Damsky, MD, PhD, discuss methods for managing a patient’s motivation and expectations when on therapy for vitiligo.

In this week’s Pointers with Dr Portela, the 208SkinDoc undergoes sugaring for hair removal.

In this video interview, James Q Del Rosso, DO, tackles the clinical impact of JAK Inhibitors and how to deal with patient concern.